Nanologica
0.48 SEK
-5.51 %
Less than 1K followers
NICA
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-5.51 %
+28.00 %
+18.67 %
-37.93 %
-61.42 %
-58.97 %
-95.44 %
-97.06 %
-97.33 %
Nanologica is a life science tools company that develops, manufactures and sells advanced input products to pharmaceutical companies. Nanologica's silica-based products are specifically designed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Nanologica operates in a global niche market for drugs for the treatment of diabetes and obesity. Nanologica was founded in 2004 and is headquartered in Södertälje.
Read moreMarket cap
157.81M SEK
Turnover
909.41K SEK
Revenue
21.13M
EBIT %
-221.49 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20.5
2026
Interim report Q1'26
21.5
2026
General meeting '26
27.8
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Syntagon AB Recruits Alexandra Pichard Nielsen as Vice President Business Development
Nanologica AB (publ) Publishes Annual Report for 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools